Study of the Relationship Between Insulin Resistance, Iron Status Markers, and Body Weight in a Sample of Egyptian Population
- Authors: Bahaaeldin A.1, Hussein M.1, Hashem S.1, Saleh A.1
- 
							Affiliations: 
							- Internal Medicine and Endocrinology Department, Faculty of Medicine, Ain Shams University, Cairo, Egypt
 
- Issue: Vol 20, No 4 (2024)
- Section: Medicine
- URL: https://cardiosomatics.ru/1573-3998/article/view/642991
- DOI: https://doi.org/10.2174/1573399820666230817102053
- ID: 642991
Cite item
Full Text
Abstract
Background:Iron plays a key role in the regulation of body iron homeostasis and is used as a clinical marker for iron deficiency (ID) and hemochromatosis. The idea that iron dysregulation may contribute to various metabolic diseases, such as obesity, insulin resistance, MetS, and T2DM, is a hot topic of discussion.
Aim:The aim of this study is to investigate the relationship insulin resistance, iron status markers, and body weight in a sample of Egyptian population.
Methods:Methods: A case control study was conducted on 90 subjects with age ranging from 18 to 70 years old from a diabetes outpatient clinic, and they were divided to three groups: Group I, non-obese- non-diabetic as the control group; Group II, obese-non-diabetic; and Group III, obese-diabetic.
Results:In our study, there was no statistically significant difference between the three studied groups regarding the different iron parameters. Similarly, we found that neither HOMA-IR nor body weight had a significant correlation with iron status markers.
Conclusion:Our study demonstrated no direct statistical significant relationship between the different iron parameters, obesity, and insulin resistance, either in the diabetic or non-diabetic subjects. This may be due to the complex metabolic dysregulation and the small number of the sample for future investigations.
:On the contrary, we detected significant positive correlations between the TIBC and the fasting blood glucose, between the serum iron and the LDL, between the TSAT and the systolic blood pressure, and between the HOMA-IR and hematocrit.
About the authors
Ahmed Bahaaeldin
Internal Medicine and Endocrinology Department, Faculty of Medicine, Ain Shams University, Cairo, Egypt
														Email: info@benthamscience.net
				                					                																			                												                														
Magda Hussein
Internal Medicine and Endocrinology Department, Faculty of Medicine, Ain Shams University, Cairo, Egypt
														Email: info@benthamscience.net
				                					                																			                												                														
Shaimaa Hashem
Internal Medicine and Endocrinology Department, Faculty of Medicine, Ain Shams University, Cairo, Egypt
														Email: info@benthamscience.net
				                					                																			                												                														
Amr Saleh
Internal Medicine and Endocrinology Department, Faculty of Medicine, Ain Shams University, Cairo, Egypt
							Author for correspondence.
							Email: info@benthamscience.net
				                					                																			                												                														
Supplementary files
 
				
			 
					 
						 
						 
						 
						 
									 
  
  
  Email this article
			Email this article 